DiaSorin To Acquire Focus Diagnostics’ Molecular And Immunoassay Product Business From Quest Diagnostics
DiaSorin S.p.A. (F TSE Italy: DIA) and Quest Diagnostics (NYSE: DGX) today announced that they have entered into a purchase agreement under which DiaSorin will buy Quest’s Focus Diagnostics, Inc. immunodiagnostic and […]




